INT14302

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.33
First Reported 1990
Last Reported 2008
Negated 0
Speculated 0
Reported most in Abstract
Documents 6
Total Number 6
Disease Relevance 3.09
Pain Relevance 0.09

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (CSF3) extracellular region (CSF3) enzyme binding (CSF3)
Anatomy Link Frequency
granulocyte 3
bone marrow 2
CSF3 (Homo sapiens)
Pain Link Frequency Relevance Heat
Pain 7 90.40 High High
headache 1 34.96 Quite Low
Piles 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Neutropenia 20 99.92 Very High Very High Very High
Monosomy 14 98.90 Very High Very High Very High
Myeloid Leukemia 9 98.54 Very High Very High Very High
Glycogen Storage Disease 6 98.48 Very High Very High Very High
Leukemia 9 98.44 Very High Very High Very High
Lymphatic System Cancer 2 97.84 Very High Very High Very High
Disease 8 96.88 Very High Very High Very High
Infection 10 92.32 High High
Pain 6 90.40 High High
Bacterial Infection 2 89.88 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
GCSF accelerates neutrophil recovery after bone marrow transplant, mobilizes bone marrow progenitor cells into peripheral blood harvesting then transplanted as supportive measures in patients undergoing intensive chemotherapy, and accelerates neutrophil recovery in patients with acute leukemias.
GCSF Binding (accelerates) of in bone marrow associated with leukemia
1) Confidence 0.33 Published 1994 Journal J Fla Med Assoc Section Abstract Doc Link 7525857 Disease Relevance 0.29 Pain Relevance 0.09
CONCLUSIONS: Accelerated paclitaxel in breast cancer patients without prophylactic GCSF is safe, avoids side effects, reduces costs and is not associated with an increase risk of neutropenic sepsis or treatment delays.


GCSF Binding (associated) of
2) Confidence 0.33 Published 2008 Journal Breast Cancer Res. Treat. Section Body Doc Link 18060493 Disease Relevance 0.06 Pain Relevance 0
They were randomized to either immediately beginning recombinant human granulocyte colony-stimulating factor (filgrastim) (3.45 to 11.50 micrograms/kg/d, subcutaneously) or entering a 4-month observation period followed by filgrastim administration.
granulocyte colony-stimulating factor Binding (beginning) of in granulocyte
3) Confidence 0.32 Published 1993 Journal Blood Section Abstract Doc Link 8490166 Disease Relevance 0.68 Pain Relevance 0
The authors administered recombinant human granulocyte colony-stimulating factor (rhG-CSF) to 16 patients with advanced non-Hodgkin's lymphoma treated with combination chemotherapy.
granulocyte colony-stimulating factor Binding (administered) of in granulocyte associated with lymphatic system cancer
4) Confidence 0.28 Published 1990 Journal Cancer Section Abstract Doc Link 1699654 Disease Relevance 0.30 Pain Relevance 0
This manuscript summarizes our experience with recombinant human granulocyte colony-stimulating factor (rhG-CSF) with high-dose Cytoxan, carmustine and etoposide (CBV in Hodgkin's disease). rhG-CSF regularly shortened the neutropenic phase following autologous bone marrow transplantation.
granulocyte colony-stimulating factor Binding (summarizes) of in bone marrow associated with disease
5) Confidence 0.27 Published 1990 Journal Int. J. Cell Cloning Section Abstract Doc Link 1691246 Disease Relevance 0.21 Pain Relevance 0
A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): A case report

Introduction

granulocyte colony-stimulating factor Binding (treatment) of in granulocyte associated with monosomy, leukemia, myeloid leukemia and glycogen storage disease
6) Confidence 0.24 Published 2008 Journal J Med Case Reports Section Title Doc Link PMC2566578 Disease Relevance 1.56 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox